Turtle Creek Wealth Advisors LLC Acquires New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Turtle Creek Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 9,491 shares of the healthcare conglomerate's stock, valued at approximately $4,971,000.

A number of other institutional investors also recently bought and sold shares of UNH. Geode Capital Management LLC lifted its position in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after purchasing an additional 319,515 shares during the last quarter. Capital International Investors lifted its position in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after purchasing an additional 906,365 shares during the period. Norges Bank bought a new position in UnitedHealth Group in the fourth quarter worth approximately $6,375,744,000. Northern Trust Corp boosted its position in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after acquiring an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. lifted its stake in shares of UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $6.52 during trading on Tuesday, hitting $294.06. 6,548,199 shares of the stock traded hands, compared to its average volume of 7,714,192. The company has a market cap of $266.75 billion, a price-to-earnings ratio of 12.31, a P/E/G ratio of 1.46 and a beta of 0.45. The company has a fifty day moving average price of $312.43 and a two-hundred day moving average price of $438.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the previous year, the firm posted $6.91 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.01%. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. Corporate insiders own 0.28% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the subject of several recent analyst reports. UBS Group reduced their price objective on shares of UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating for the company in a research note on Wednesday, June 25th. Mizuho dropped their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a report on Friday, June 20th. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research report on Monday, May 19th. Finally, Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $415.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.